Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

NCT05651828 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Advanced Basal Cell Carcinoma

Interventions

DRUG: Vismodegib 150 MG Oral Capsule

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]